Eton Pharmaceutical | 10-Q: Quarterly report
Eton Pharmaceutical | 8-K: Current report
Eton Pharmaceutical | 8-K: Current report
Eton Pharmaceutical | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Harrow, Inc.(0.0%)
Eton Pharmaceutical | DEF 14A: Definitive information statements
Eton Pharmaceutical | 8-K: Current report
Eton Pharmaceutical | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Eton Pharmaceutical | 10-K/A: Annual report (Amendment)
Eton Pharmaceutical | 8-K: Current report
Eton Pharmaceutical | 10-K: Annual report
Eton Pharmaceutical | 8-K: Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Eton Pharmaceutical | 8-K: Current report
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Gruber James R.
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer BRYNJELSEN SEAN
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Adams Jennifer McKie
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director CASAMENTO CHARLES J
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director RIEDEL NORBERT G
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director MAIER PAUL V
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Krempa David
Eton Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Opaleye Management, Inc.(9.84%)
No Data